Table 2 Characteristics of the tumours of breast cancer patients1.
Tumour characteristics | HER-2/neu + n = 145 (%) | HER-2/neu- n = 233 (%) | p value |
|---|---|---|---|
Age at interview | 0.533 | ||
≤ 50 years | 55 (40) | 81 (60) | |
>50 years | 90 (37) | 152 (63) | |
Staging | 0.106 | ||
I | 30 (45) | 36 (55) | |
II | 76 (35) | 143 (65) | |
III | 20 (34) | 39 (66) | |
IV | 2 (50) | 2 (50) | |
Unknown | 17 (57) | 13 (43) | |
Tumour size | 0.161 | ||
T1 | 55 (44) | 71 (56) | |
T2 | 65 (35) | 121 (65) | |
>T3 | 10 (29) | 25 (71) | |
Unknown | 15 (48) | 16 (52) | |
Menopausal status | 0.762 | ||
Pre/perimenopausal | 52 (40) | 80 (60) | |
Postmenopausal | 93 (38) | 153 (62) | |
Grading | 0.577 | ||
I | 7 (33) | 14 (67) | |
II | 64 (36) | 113 (64) | |
III | 60 (43) | 80 (57) | |
Unknown | 14 (35) | 26 (65) | |
Node Status | 0.119 | ||
Negative | 55 (33) | 112 (67) | |
Positive | 89 (43) | 118 (57) | |
Unknown | 1 (25) | 3 (75) | |
Estrogen receptor status | 0.108 | ||
Er+ | 60 (33) | 120 (67) | |
Er - | 85 (43) | 112 (57) | |
Unknown | 1 | ||
Progesterone receptor status | 0.038 | ||
Pr+ | 49 (49) | 52 (51) | |
Pr- | 96 (35) | 180 (65) | |
Unknown | 1 |